{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T07:11:42Z","timestamp":1778742702006,"version":"3.51.4"},"reference-count":17,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2019,12,16]],"date-time":"2019-12-16T00:00:00Z","timestamp":1576454400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Wockhardt Ltd, India"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Levonadifloxacin is a novel antibiotic belonging to the benzoquinolizine subclass of fluoroquinolones with potent activity against MRSA and quinolone-resistant Staphylococcus aureus. IV levonadifloxacin and its oral prodrug alalevonadifloxacin have recently been approved in India for the treatment of acute bacterial skin and skin structure infections (ABSSSIs) including diabetic foot infections.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To investigate the in vitro activity of levonadifloxacin against contemporary clinical isolates collected from multiple tertiary care hospitals across India in the Antimicrobial Susceptibility Profiling of Indian Resistotypes (ASPIRE) surveillance study.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A total of 1376 clinical isolates, consisting of staphylococci (n\u2009=\u2009677), streptococci (n\u2009=\u2009178), Enterobacterales (n\u2009=\u2009320), Pseudomonas aeruginosa (n\u2009=\u2009140) and Acinetobacter baumannii (n\u2009=\u200961), collected (2016\u201318) from 16 tertiary hospitals located across 12 states in India, were included in the study. The MICs of levonadifloxacin and comparator antibiotics were determined using the reference agar dilution method and broth microdilution method.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Levonadifloxacin exhibited potent activity against MSSA (MIC50\/90: 0.5\/1\u2009mg\/L), MRSA (MIC50\/90: 0.5\/1\u2009mg\/L) and levofloxacin-resistant S. aureus (MIC50\/90: 1\/1\u2009mg\/L) isolates. Similarly, potent activity of levonadifloxacin was also observed against CoNS including MDR isolates (MIC50\/90: 1\/2\u2009mg\/L). Against Streptococcus pneumoniae, levonadifloxacin (MIC50\/90: 0.5\/0.5\u2009mg\/L) showed superior activity compared with levofloxacin (MIC50\/90: 1\/2\u2009mg\/L). Among levofloxacin-susceptible Enterobacterales, 80.6% of isolates were inhibited at \u22642\u2009mg\/L levonadifloxacin.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Levonadifloxacin displayed potent activity against contemporary MRSA and fluoroquinolone-resistant staphylococcal isolates, thus offering a valuable IV as well as an oral therapeutic option for the treatment of ABSSSIs. Furthermore, levonadifloxacin exhibited a broad-spectrum activity profile as evident from its activity against streptococci and levofloxacin-susceptible Gram-negative isolates.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jac\/dkz493","type":"journal-article","created":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T15:10:16Z","timestamp":1572966616000},"page":"600-608","source":"Crossref","is-referenced-by-count":26,"title":["In vitro activity of a novel antibacterial agent, levonadifloxacin, against clinical isolates collected in a prospective, multicentre surveillance study in India during 2016\u201318"],"prefix":"10.1093","volume":"75","author":[{"given":"Boppe","family":"Appalaraju","sequence":"first","affiliation":[{"name":"Department of Microbiology, PSG Institute of Medical Sciences and Research, Peelamedu, Coimbatore, Tamil Nadu, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sujata","family":"Baveja","sequence":"first","affiliation":[{"name":"Department of Microbiology, Lokmanya Tilak Municipal General Hospital and Lokmanya Tilak Municipal Medical College, Sion, Mumbai, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shrikala","family":"Baliga","sequence":"first","affiliation":[{"name":"Department of Microbiology, Kasturba Medical College, Mangalore, Manipal Academy of Higher Education, Karnataka, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suchitra","family":"Shenoy","sequence":"first","affiliation":[{"name":"Department of Microbiology, Kasturba Medical College, Mangalore, Manipal Academy of Higher Education, Karnataka, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renu","family":"Bhardwaj","sequence":"first","affiliation":[{"name":"Department of Microbiology, Byramjee Jeejeebhoy Government Medical College and Sassoon Hospitals, Pune, Maharashtra, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vaishali","family":"Kongre","sequence":"first","affiliation":[{"name":"Department of Microbiology, Byramjee Jeejeebhoy Government Medical College and Sassoon Hospitals, Pune, Maharashtra, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gogi Suresh","family":"Dattatraya","sequence":"first","affiliation":[{"name":"Department of Microbiology, DM Wayanad Institute of Medical Sciences, Wayanad, Kerala, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tapan","family":"Dhole","sequence":"first","affiliation":[{"name":"Department of Microbiology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Binita","family":"Verma","sequence":"first","affiliation":[{"name":"Department of Microbiology, Shree Jagannath Hospital & Research Centre, Ranchi Jharkhand, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D N","family":"Mukherjee","sequence":"first","affiliation":[{"name":"Department of Microbiology, Woodlands Multispeciality Hospital Ltd, Kolkata, West Bengal, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shalini","family":"Gupta","sequence":"first","affiliation":[{"name":"Department of Microbiology, Somani Hospital, Jaipur, Rajasthan, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priyadarshini","family":"Shanmugam","sequence":"first","affiliation":[{"name":"Department of Microbiology, Chettinad Hospital and Research Institute, Chettinad Academy of Research and Education, Chennai, Tamil Nadu, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jyoti","family":"Iravane","sequence":"first","affiliation":[{"name":"Department of Microbiology, Government Medical College, Aurangabad, Maharashtra, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sudhi Ranjan","family":"Mishra","sequence":"first","affiliation":[{"name":"Department of Microbiology, Aditya Care Hospital, Bhubaneswar, Odisha, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Purabi","family":"Barman","sequence":"first","affiliation":[{"name":"Department of Microbiology, BLK Super Speciality Hospital, New Delhi, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shimpi","family":"Chopra","sequence":"first","affiliation":[{"name":"Department of Microbiology, BLK Super Speciality Hospital, New Delhi, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meenakshi","family":"Hariharan","sequence":"first","affiliation":[{"name":"Department of Microbiology, Down Town Hospital, Guwahati, Assam, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajendra","family":"Surpam","sequence":"first","affiliation":[{"name":"Department of Microbiology, Government Medical College and Hospital, Nagpur, Maharashtra, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rana","family":"Pratap","sequence":"first","affiliation":[{"name":"Department of Microbiology, Narayan Medical College and Hospital, Jamuhar, Bihar, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prashant","family":"Joshi","sequence":"first","affiliation":[{"name":"Drug Discovery Research, Wockhardt Research Centre, Aurangabad, Maharashtra, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hemant","family":"Khande","sequence":"first","affiliation":[{"name":"Drug Discovery Research, Wockhardt Research Centre, Aurangabad, Maharashtra, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashish","family":"Mane","sequence":"first","affiliation":[{"name":"Medical Affairs, Wockhardt Ltd, Mumbai, Maharashtra, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rishi","family":"Jain","sequence":"first","affiliation":[{"name":"Medical Affairs, Wockhardt Ltd, Mumbai, Maharashtra, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachin","family":"Bhagwat","sequence":"first","affiliation":[{"name":"Drug Discovery Research, Wockhardt Research Centre, Aurangabad, Maharashtra, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2019,12,16]]},"reference":[{"key":"2020021410594569000_dkz493-B1","doi-asserted-by":"crossref","first-page":"4754","DOI":"10.1128\/AAC.48.12.4754-4761.2004","article-title":"Antistaphylococcal activity of WCK 771, a tricyclic fluoroquinolone, in animal infection models","volume":"48","author":"Patel","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"2020021410594569000_dkz493-B2","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1093\/jac\/dki361","article-title":"Activity of the new quinolones WCK 771, WCK 1152 and WCK 1153 against clinical isolates of Streptococcus pneumoniae and Streptococcus pyogenes","volume":"56","author":"Al-Lahham","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"2020021410594569000_dkz493-B3","doi-asserted-by":"crossref","first-page":"3338","DOI":"10.1128\/AAC.48.9.3338-3342.2004","article-title":"In vitro activity of the new quinolone WCK 771 against staphylococci","volume":"48","author":"Jacobs","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"2020021410594569000_dkz493-B4","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1128\/AAC.01150-08","article-title":"In vitro activity of the quinolone WCK 771 against recent U.S. hospital and community-acquired Staphylococcus aureus pathogens with various resistance types","volume":"53","author":"Bhagwat","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"2020021410594569000_dkz493-B5","author":"Flamm"},{"key":"2020021410594569000_dkz493-B6","volume-title":"Annual Report Antimicrobial Resistance Surveillance Network Jan 2018 - Dec 2018","author":"Walia","year":"2019"},{"key":"2020021410594569000_dkz493-B7","year":"2015"},{"key":"2020021410594569000_dkz493-B8","year":"2019"},{"key":"2020021410594569000_dkz493-B9","first-page":"363","article-title":"Methicillin resistant Staphylococcus aureus (MRSA) in India: prevalence & susceptibility pattern","volume":"137","year":"2013","journal-title":"Indian J Med Res"},{"key":"2020021410594569000_dkz493-B10","doi-asserted-by":"crossref","first-page":"53","DOI":"10.4103\/ijmm.IJMM_16_427","article-title":"Prevalence and genetic mechanisms of antimicrobial resistance in Staphylococcus species: a multicentre report of the indian council of medical research antimicrobial resistance surveillance network","volume":"35","author":"Rajkumar","year":"2017","journal-title":"Indian J Med Microbiol"},{"key":"2020021410594569000_dkz493-B11","volume-title":"Scoping Report on Antimicrobial Resistance in India","author":"Gandra","year":"2017"},{"key":"2020021410594569000_dkz493-B12","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1128\/AAC.00641-06","article-title":"The anti-methicillin-resistant Staphylococcus aureus quinolone WCK 771 has potent activity against sequentially selected mutants, has a narrow mutant selection window against quinolone-resistant Staphylococcus aureus, and preferentially targets DNA gyrase","volume":"50","author":"Bhagwat","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"2020021410594569000_dkz493-B13","doi-asserted-by":"crossref","first-page":"5232","DOI":"10.1021\/jm050035f","article-title":"A chiral benzoquinolizine-2-carboxylic acid arginine salt active against vancomycin-resistant Staphylococcus aureus","volume":"48","author":"de Souza","year":"2005","journal-title":"J Med Chem"},{"key":"2020021410594569000_dkz493-B14","doi-asserted-by":"crossref","first-page":"e01348","DOI":"10.1128\/AAC.01348-18","article-title":"In vitro activities of the benzoquinolizine fluoroquinolone levonadifloxacin (WCK 771) and other antimicrobial agents against mycoplasmas and ureaplasmas in humans, including isolates with defined resistance mechanisms","volume":"62","author":"Xue","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"2020021410594569000_dkz493-B15","doi-asserted-by":"crossref","first-page":"e01048","DOI":"10.1128\/AAC.01048-19","article-title":"In vitro activity of levonadifloxacin (WCK 771) against Chlamydia pneumoniae","volume":"63","author":"Kohlhoff","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"2020021410594569000_dkz493-B16","author":"Dubois"},{"key":"2020021410594569000_dkz493-B17","doi-asserted-by":"crossref","first-page":"e02297","DOI":"10.1128\/AAC.01089-18","article-title":"Intrapulmonary pharmacokinetics of levonadifloxacin following oral administration of alalevonadifloxacin to healthy adult subjects","volume":"62","author":"Rodvold","year":"2018","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/75\/3\/600\/32469862\/dkz493.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/75\/3\/600\/32469862\/dkz493.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,14]],"date-time":"2020-02-14T11:00:49Z","timestamp":1581678049000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/75\/3\/600\/5678110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,16]]},"references-count":17,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,12,16]]},"published-print":{"date-parts":[[2020,3,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkz493","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,3]]},"published":{"date-parts":[[2019,12,16]]}}}